What is new in the management of acute coronary syndromes

2019-05-24

Zaza Iakobishvili

This lecture was recorded at the 4th McMaster International Review Course in Internal Medicine in Kraków, Poland. To learn more, visit www.mircim.eu.

See also

The most frequent causes of medical errors: how to avoid them A lecture by Dr Melvin S. Blanchard, from Washington University School of Medicine in St. Louis, USA, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
How to keep patients with chronic heart failure out of hospital A lecture by Dr Harriette Van Spall, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine in Kraków in May 2018.
Antihypertensive treatment in young patients with mildly elevated BP Should antihypertensive treatment be introduced in young patients with a mildly elevated systolic or diastolic blood pressure?
Invasive treatment in STEMI: PCI of the culprit vessel vs a multivessel approach Which invasive treatment strategy is preferred in ST-segment elevation myocardial infarction (STEMI): PCI of the infarct-related artery only or revascularization of all significant lesions?
Diuretic treatment in heart failure How to plan diuretic treatment in patients with heart failure to prevent volume overload? Should the treatment be based on the presence of edema or other symptoms or on B-type natriuretic peptide (BNP) levels?
RBBB as an indication for coronary angiography In 2017 ESC guidelines on STEMI management, the presence of RBBB, similarly to LBBB, is now an indication for urgent coronary angiography in patients with symptoms of myocardial ischemia. What is this based on? Should every patient with features of MI and RBBB in ECG undergo urgent coronary angiography? Does it apply only to patients with a new block or also to those with a preexisting block?
Management of MI depending on age Should the management of myocardial infarction (MI) vary depending on the patient’s age?
Roles of CK and CK-MB in suspected myocardial infarction Is there still a role for creatine kinase (CK) or creatine kinase–myocardial band (CK-MB) in a patient with suspected myocardial infarction (MI)?
New definition of myocardial infarction and its practical implications A lecture by Dr P.J. Devereaux, from McMaster University, Canada, delivered at McMaster International Review Course in Internal Medicine (MIRCIM) in May 2019.
Beta-blockers and treatment of hypertension Is there still a place for beta-blockers in the treatment of hypertension?

What is new in the management of acute coronary syndromes

Social Media